Lokalize Prostat Kanserinde Fokal Tedavi Yöntemleri

Cancer stat facts: prostate cancer. National Cancer Institute. https://seer.cancer. gov/statfacts/html/prost.html.. Accessed January 9, 2020.

Ficarra, V., et al., Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol, 2012. 62(3): p. 405-17.

Pinsky, P.F., H.L. Parnes, and G. Andriole, Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial. BJU Int, 2014. 113(2): p. 254-9.

Stamey, T.A., et al., Secondary cancers in the prostate do not determine PSA biochemical failure in untreated men undergoing radical retropubic prostatectomy. Eur Urol, 2001. 39 Suppl 4: p. 22-3.

Blana, A., et al., High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology, 2004. 63(2): p. 297-300.

Barkin, J., High intensity focused ultrasound (HIFU). Can J Urol, 2011. 18(2): p. 5634-43.

Crouzet, S., et al., High intensity focused ultrasound (HIFU) for prostate cancer: current clinical status, outcomes and future perspectives. Int J Hyperthermia, 2010. 26(8): p. 796-803.

Ahmed, H.U., C. Moore, and M. Emberton, Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Surg Oncol, 2009. 18(3): p. 219-32.

Crouzet, S., et al., Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients. Eur Urol, 2010. 58(4): p. 559-66.

Guillaumier, S., et al., A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. Eur Urol, 2018. 74(4): p. 422-429.

Albisinni, S., et al., Focal Treatment for Unilateral Prostate Cancer Using High-Intensity Focal Ultrasound: A Comprehensive Study of Pooled Data. J Endourol, 2018. 32(9): p. 797-804.

Mortezavi, A., et al., Extensive Histological Sampling following Focal Therapy of Clinically Significant Prostate Cancer with High Intensity Focused Ultrasound. J Urol, 2019. 202(4): p. 717-724.

Colin, P., et al., Focal laser ablation of prostate cancer: definition, needs, and future. Adv Urol, 2012. 2012: p. 589160.

Stafford, R.J., et al., Magnetic resonance guided, focal laser induced interstitial thermal therapy in a canine prostate model. J Urol, 2010. 184(4): p. 1514-20.

Eggener, S.E., et al., Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer. J Urol, 2016. 196(6): p. 1670-1675.

Feller J, G.B., Jones W, Toth R. Transrectally delivered, outpatient MRI-guided laser focal therapy of prostate cancer: seven year interim results of NCT. in AUA abstract MP30-02. 2018. J Urol.

Walser, E., et al., Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low- to Intermediate-Risk Disease. J Vasc Interv Radiol, 2019. 30(3): p. 401-409.e2.

Natarajan, S., et al., Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance. J Urol, 2017. 198(4): p. 839-847.

Ahdoot, M., et al., Contemporary treatments in prostate cancer focal therapy. Curr Opin Oncol, 2019. 31(3): p. 200-206.

Onik, G., P. Mikus, and B. Rubinsky, Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat, 2007. 6(4): p. 295-300.

van den Bos, W., et al., Focal irreversible electroporation as primary treatment for localized prostate cancer. BJU Int, 2018. 121(5): p. 716-724.

Valerio, M., et al., Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer. Prostate Cancer Prostatic Dis, 2014. 17(4): p. 343-7.

Blazevski, A., et al., Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort. Eur Urol Oncol, 2020. 3(3): p. 283-290.

Collettini, F., et al., Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes. Radiology, 2019. 292(1): p. 250-257.

Windahl, T., S.O. Andersson, and L. Lofgren, Photodynamic therapy of localised prostatic cancer. Lancet, 1990. 336(8723): p. 1139.

Valerio, M., et al., New and Established Technology in Focal Ablation of the Prostate: A Systematic Review. Eur Urol, 2017. 71(1): p. 17-34.

Azzouzi, A.R., et al., TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer. BJU Int, 2013. 112(6): p. 766-74.

Moore, C.M., et al., Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy. BJU Int, 2015. 116(6): p. 888-96.

Azzouzi, A.R., et al., Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. Lancet Oncol, 2017. 18(2): p. 181-191.

Gill, I.S., et al., Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness. J Urol, 2018. 200(4): p. 786-793.

Hoffmann, N.E. and J.C. Bischof, The cryobiology of cryosurgical injury. Urology, 2002. 60(2 Suppl 1): p. 40-9.

Gangi, A., et al., Percutaneous MR-guided cryoablation of prostate cancer: initial experience. Eur Radiol, 2012. 22(8): p. 1829-35.

Nguyen, H.D., B.J. Allen, and J.M. Pow-Sang, Focal cryotherapy in the treatment of localized prostate cancer. Cancer Control, 2013. 20(3): p. 177-80.

Tay, K.J., et al., Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data. J Endourol, 2017. 31(6): p. 564-571.

Tay, K.J., et al., Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project. Prostate Cancer Prostatic Dis, 2017. 20(3): p. 294-299.

de la Rosette, J., et al., Focal therapy in prostate cancer-report from a consensus panel. J Endourol, 2010. 24(5): p. 775-80.